Sanofi India Ltd., a Mid Cap pharmaceutical company, has received a hold call from ICICI Securities, with a target price of Rs 9170. Recently, Sanofi India reported a Consolidated Total Income of Rs 705.90 Crore for the quarter ended 31-12-2023.
Sanofi India Ltd., a Mid Cap pharmaceutical company, has received a hold call from ICICI Securities, with a target price of Rs 9170. Recently, Sanofi India reported a Consolidated Total Income of Rs 705.90 Crore for the quarter ended 31-12-2023.